Format
Sort by
Items per page

Send to

Choose Destination

Best matches for alzheimer's cfh:

Search results

Items: 1 to 20 of 29

1.

Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration.

Zhao Y, Lukiw WJ.

Mol Neurobiol. 2018 Dec;55(12):9100-9107. doi: 10.1007/s12035-018-1015-y. Epub 2018 Apr 10. Review.

PMID:
29637444
2.

Alterations in micro RNA-messenger RNA (miRNA-mRNA) Coupled Signaling Networks in Sporadic Alzheimer's Disease (AD) Hippocampal CA1.

Jaber V, Zhao Y, Lukiw WJ.

J Alzheimers Dis Parkinsonism. 2017 Apr;7(2). pii: 312. doi: 10.4172/2161-0460.1000312. Epub 2017 Mar 10.

3.

Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.

Wang D, Di X, Fu L, Li Y, Han X, Wu H, Cai L, Meng X, Jiang C, Kong W, Su W.

Neuroreport. 2016 Oct 19;27(15):1114-9. doi: 10.1097/WNR.0000000000000661.

PMID:
27541273
4.

Oxidative stress, innate immunity, and age-related macular degeneration.

Shaw PX, Stiles T, Douglas C, Ho D, Fan W, Du H, Xiao X.

AIMS Mol Sci. 2016;3(2):196-221. Epub 2016 May 11.

5.

Age-Related Macular Degeneration-Associated Genes in Alzheimer Disease.

Williams MA, McKay GJ, Carson R, Craig D, Silvestri G, Passmore P.

Am J Geriatr Psychiatry. 2015 Dec;23(12):1290-1296. doi: 10.1016/j.jagp.2015.06.005. Epub 2015 Jun 24.

PMID:
26419733
6.

CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease.

Zhang DF, Li J, Wu H, Cui Y, Bi R, Zhou HJ, Wang HZ, Zhang C, Wang D; Alzheimer's Disease Neuroimaging Initiative (ADNI), Kong QP, Li T, Fang Y, Jiang T, Yao YG.

Neuropsychopharmacology. 2016 Mar;41(4):1034-45. doi: 10.1038/npp.2015.232. Epub 2015 Aug 5.

7.

Plasma Complement factor H in Alzheimer's Disease.

Williams MA, Haughton D, Stevenson M, Craig D, Passmore AP, Silvestri G.

J Alzheimers Dis. 2015;45(2):369-72. doi: 10.3233/JAD-142742.

PMID:
25589717
8.

Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.

Clark SJ, Schmidt CQ, White AM, Hakobyan S, Morgan BP, Bishop PN.

J Immunol. 2014 Nov 15;193(10):4962-70. doi: 10.4049/jimmunol.1401613. Epub 2014 Oct 10.

9.

Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases.

Kotwal GJ, Fernando N, Zhou J, Valter K.

Mol Immunol. 2014 Oct;61(2):204-9. doi: 10.1016/j.molimm.2014.06.022. Epub 2014 Jul 19. Review.

PMID:
25052409
10.

BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.

Gezen-Ak D, Dursun E, Hanağası H, Bilgiç B, Lohman E, Araz ÖS, Atasoy IL, Alaylıoğlu M, Önal B, Gürvit H, Yılmazer S.

J Alzheimers Dis. 2013;37(1):185-95. doi: 10.3233/JAD-130497.

PMID:
23948885
11.

Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation.

Khandhadia S, Hakobyan S, Heng LZ, Gibson J, Adams DH, Alexander GJ, Gibson JM, Martin KR, Menon G, Nash K, Sivaprasad S, Ennis S, Cree AJ, Morgan BP, Lotery AJ.

Ophthalmology. 2013 Aug;120(8):1612-8. doi: 10.1016/j.ophtha.2013.01.004. Epub 2013 Apr 4.

PMID:
23562165
12.

Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH.

Killick R, Hughes TR, Morgan BP, Lovestone S.

Neurosci Lett. 2013 Jan 15;533:96-9. doi: 10.1016/j.neulet.2012.11.008. Epub 2012 Nov 12. Erratum in: Neurosci Lett. 2013 Jun 17;545:144.

13.

The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.

Santhekadur PK, Rajasekaran D, Siddiq A, Gredler R, Chen D, Schaus SE, Hansen U, Fisher PB, Sarkar D.

Am J Cancer Res. 2012;2(3):269-85. Epub 2012 Apr 21.

14.

Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA.

Lukiw WJ, Alexandrov PN, Zhao Y, Hill JM, Bhattacharjee S.

Neuroreport. 2012 Jul 11;23(10):621-6. doi: 10.1097/WNR.0b013e32835542b0.

15.

Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).

Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN.

Int J Biochem Mol Biol. 2012;3(1):105-16. Epub 2012 Mar 20.

16.
17.

Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation.

Proitsi P, Lupton MK, Dudbridge F, Tsolaki M, Hamilton G, Daniilidou M, Pritchard M, Lord K, Martin BM, Johnson J, Craig D, Todd S, McGuinness B, Hollingworth P, Harold D, Kloszewska I, Soininen H, Mecocci P, Velas B, Gill M, Lawlor B, Rubinsztein DC, Brayne C, Passmore PA, Williams J, Lovestone S, Powell JF.

Neurobiol Aging. 2012 Aug;33(8):1843.e9-17. doi: 10.1016/j.neurobiolaging.2011.12.036. Epub 2012 Feb 1. Erratum in: Neurobiol Aging. 2013 Jan;34(1):355. Johnson, Janet [added].

PMID:
22300950
18.

miRNA-155 upregulation and complement factor H deficits in Down's syndrome.

Li YY, Alexandrov PN, Pogue AI, Zhao Y, Bhattacharjee S, Lukiw WJ.

Neuroreport. 2012 Feb 15;23(3):168-73. doi: 10.1097/WNR.0b013e32834f4eb4.

19.

c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes.

Fraczek LA, Martin CB, Martin BK.

Mol Immunol. 2011 Oct;49(1-2):201-10. doi: 10.1016/j.molimm.2011.08.013. Epub 2011 Sep 14.

20.

Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells.

Li YY, Cui JG, Dua P, Pogue AI, Bhattacharjee S, Lukiw WJ.

Neurosci Lett. 2011 Jul 20;499(2):109-13. doi: 10.1016/j.neulet.2011.05.044. Epub 2011 May 26. Erratum in: Neurosci Lett. 2012 Jun 27;520(1):126.

Supplemental Content

Loading ...
Support Center